Evogene Ltd. Logo

Evogene Ltd.

AI-powered platform designing life-science solutions for health, ag, and industrial sectors.

EVGN | TA

Overview

Corporate Details

ISIN(s):
IL0011050551
LEI:
Country:
Israel
Address:
13 Gad Feinstein St., Park Rehovot, 7638517 Rehovot
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Evogene Ltd. is a computational biology company that aims to revolutionize the discovery and development of life-science products. At its core is the proprietary Computational Predictive Biology (CPB) platform, which leverages big data and advanced artificial intelligence to design novel solutions based on microbes, small molecules, and genetic elements. The platform's tech-engines are designed to increase the probability of success while reducing development time and costs. Evogene's solutions cater to the human health, agriculture, and industrial sectors. The company operates through a group structure, licensing its technology to subsidiary companies that focus on specific commercial applications, thereby driving innovation across multiple life-science markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-30 16:15
Registration Form
POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-1
English 551.8 KB
2025-09-30 16:15
Foreign Filer Report
POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-1
English 36.4 KB
2025-09-30 16:00
Foreign Filer Report
Results of Operations- Six Months Ended June 30, 2025
English 372.7 KB
2025-09-30 16:00
Foreign Filer Report
Results of Operations- Six Months Ended June 30, 2025
English 36.5 KB
2025-09-10 16:00
Foreign Filer Report
Evogene Investor Presentation
English 1.8 MB
2025-09-10 16:00
Foreign Filer Report
Evogene Investor Presentation
English 36.5 KB
2025-08-28 16:00
Report Publication Announcement
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference …
English 110.4 KB
2025-08-28 16:00
Foreign Filer Report
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference …
English 36.6 KB
2025-08-19 16:00
Foreign Filer Report
Reports Second Quarter 2025 Financial Results
English 2.2 MB
2025-08-19 16:00
Foreign Filer Report
Reports Second Quarter 2025 Financial Results
English 36.7 KB
2025-08-19 01:00
Foreign Filer Report
Other Report or Announcement
English 122.5 KB
2025-08-12 16:00
Regulatory News Service
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboratio…
English 135.0 KB
2025-08-12 16:00
Foreign Filer Report
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboratio…
English 36.6 KB
2025-08-12 01:00
Foreign Filer Report
Other Report or Announcement
English 63.2 KB
2025-08-12 01:00
Foreign Filer Report
Other Report or Announcement
English 36.5 KB

Automate Your Workflow. Get a real-time feed of all Evogene Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Evogene Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Optipharm.CO.,LTD Logo
Biotech for animal health and xenotransplantation using genetically engineered pig organs.
South Korea 153710
Organoid-based platforms for drug testing and regenerative therapeutics.
South Korea 476040
Oricon Inc. Logo
Provides entertainment industry data, music charts, web media, and marketing services.
Japan 4800
ORIENTBIO Inc. Logo
Provides animal models & technical services for preclinical R&D to pharma & research institutions.
South Korea 002630
Oryzon Genomics S.A. Logo
Develops epigenetic-based medicines for cancer and central nervous system disorders.
Spain ORY
OSCOTECInc. Logo
A clinical-stage drug discovery company developing innovative medicines for unmet needs.
South Korea 039200
OSE Immunotherapeutics Logo
Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.
France OSE
Oxurion NV Logo
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
Belgium OXUR
PA Co., Ltd Logo
Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.
Japan 4766
PCI Biotech Holding Logo
Biopharma firm evaluating its future after discontinuing its core technology development.
Norway PCIB

Talk to a Data Expert

Have a question? We'll get back to you promptly.